Frequently Asked Questions
What are vector-borne Diseases?
Vector-borne diseases are infections transmitted by the bites of infected arthropods (mosquitoes, sandflies, blackflies, ticks etc).
What insects does NO MO repel and what disease does it protect you from?
Anophelines (vectors for malaria and lymphatic filariasis) : Anopheles gambiae, An. melus, An. funestus, An. arabiensis, An stephensi, An. darlingi, An dirus etc. Culex (vectors for lymphatic filariasis and encephalitis): Culex quinquefasciatus; Culex pipiens etc. Aedines (vectors for dengue, chikungunya, yellow fever, Zika etc): Aedes aegypti, Aedes albopictus. Phlebotomines (vector for leishmaniasis): Lutzomyia longipalpis
Does the repellent protect against Ticks and Lyme disease?
A tick’s anatomy and behavior is quite different from mosquitos and flies, and the repellent has demonstrated little efficacy against them.
Where can I buy the repellent in Africa?
NO MO is now available throughout Ghana, and for a list of vendors there contact Joseph Ado-Yobo (firstname.lastname@example.org). In 2017 the product will be registered in Nigeria, Kenya, Tanzania, and Uganda.
Can I buy the repellent outside Africa?
Global rights to distribute NO MO for profit have been licensed by Sam Darling, the repellent developer, to Verde Health, a US corporation. Royalties that Mr. Darling receives are being donated to support the NO MO Foundation’s distribution of the repellent below cost in Africa. Africa is reserved exclusively for the non-profit distribution of the repellent by the NO MO Foundation. Verde is currently working on EPA approval in the US and will start distributing the product there in the near future. For more information contact: (email@example.com)
How can I become a distributor in Africa?
Once NO MO repellent is registered in a country you can purchase the repellent from our local Master Distributor. For more information, contact our African manager, Joseph Ado-Yobo (firstname.lastname@example.org)
How can the repellent be purchased for a field trial?
We value evidence-based research to study the effectiveness of NO MO at reducing disease. We encourage further trials and are willing to offer the repellent at cost to those who want to conduct them.